1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legal & IP

FDA Opens Device Criminal Investigations Under Pilot Program In 2011

Despite the name, FDA’s “Pharmaceutical Fraud Pilot Program” includes devices in its mission. Of the 16 criminal investigations opened under the program last year, two are explicitly focused on device companies.

An ongoing FDA “pharmaceutical fraud” pilot program includes medical devices among its targets, and at least two of the 16 criminal investigations opened in 2011 under the program are device focused, according to a government report.

Attorney General Eric Holder and HHS Secretary Kathleen Sebelius released the fiscal 2011

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Policy & Regulation

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.

Permanent FDA Top Lawyer Expected After HHS Counsel Confirmation

 
• By Sue Sutter

Robert Foster, HHS deputy general counsel and chief counsel for food, research and drugs, is temporarily heading the Office of Chief Counsel, but a permanent appointee is expected after Michael Stuart's confirmation as HHS general counsel.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 
• By Brian Bossetta

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.